Healthcare provider profile · identity verified

Radhika Kalisetti, M.D.

Hospitalist · BURLINGTON, NC · NPI 1376711713

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	380	118
Atorvastatin Calcium	Atorvastatin Calcium	372	116
Levothyroxine Sodium	Levothyroxine Sodium	316	89
Gabapentin	Gabapentin	294	86
Rosuvastatin Calcium	Rosuvastatin Calcium	244	73
Losartan Potassium	Losartan Potassium	236	70
Pantoprazole Sodium	Pantoprazole Sodium	231	66
Omeprazole	Omeprazole	210	65
Furosemide	Furosemide	181	58
Metoprolol Succinate	Metoprolol Succinate	161	44
Meloxicam	Meloxicam	145	53
Lisinopril	Lisinopril	141	43
Duloxetine Hcl	Duloxetine Hcl	140	32
Hydrochlorothiazide	Hydrochlorothiazide	139	43
Simvastatin	Simvastatin	135	38
Trazodone Hcl	Trazodone Hcl	133	47
Metformin Hcl	Metformin Hcl	131	40
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	111	43
Glipizide Er	Glipizide	110	32
Metformin Hcl Er	Metformin Hcl	110	30
Celecoxib	Celecoxib	107	25
Ozempic	Semaglutide	101	23
Pravastatin Sodium	Pravastatin Sodium	98	27
Mounjaro	Tirzepatide	95	17
Montelukast Sodium	Montelukast Sodium	91	26
Albuterol Sulfate Hfa	Albuterol Sulfate	90	44
Potassium Chloride	Potassium Chloride	89	32
Bupropion Xl	Bupropion Hcl	87	23
Ezetimibe	Ezetimibe	85	27
Sertraline Hcl	Sertraline Hcl	84	24
Alprazolam	Alprazolam	82	26
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	81	24
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	78	59
Citalopram Hbr	Citalopram Hydrobromide	77	22
Fluticasone Propionate	Fluticasone Propionate	77	31
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	70	15
Eliquis	Apixaban	68	15
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	66	21
Venlafaxine Hcl Er	Venlafaxine Hcl	66	19
Prednisone	Prednisone	64	51
Allopurinol	Allopurinol	63	17
Januvia	Sitagliptin Phosphate	62	16
Methylprednisolone	Methylprednisolone	62	51
Metoprolol Tartrate	Metoprolol Tartrate	62	21
Ciprofloxacin Hcl	Ciprofloxacin Hcl	59	46
Tamsulosin Hcl	Tamsulosin Hcl	58	17
Alendronate Sodium	Alendronate Sodium	57	20
Tramadol Hcl	Tramadol Hcl	57	32
Famotidine	Famotidine	56	17
Jardiance	Empagliflozin	56	14
Oxybutynin Chloride Er	Oxybutynin Chloride	56	16
Ropinirole Hcl	Ropinirole Hcl	56	11
Fluoxetine Hcl	Fluoxetine Hcl	55	13
Clopidogrel	Clopidogrel Bisulfate	54	18
Escitalopram Oxalate	Escitalopram Oxalate	52	15
Fenofibrate	Fenofibrate Nanocrystallized	51	13
Fluconazole	Fluconazole	51	31
Mirtazapine	Mirtazapine	51	14
Pregabalin	Pregabalin	51	20
Linzess	Linaclotide	50	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	48	22
Hydroxyzine Hcl	Hydroxyzine Hcl	47	20
Zolpidem Tartrate	Zolpidem Tartrate	47	16
Azithromycin	Azithromycin	45	37
Synthroid	Levothyroxine Sodium	44	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	43	13
Atenolol	Atenolol	43	14
Baclofen	Baclofen	43	14
Hydralazine Hcl	Hydralazine Hcl	42	15
Estradiol	Estradiol	40	12
Clonazepam	Clonazepam	39	13
Buspirone Hcl	Buspirone Hcl	38	suppressed
Methocarbamol	Methocarbamol	38	18
Nystatin	Nystatin	38	29
Oxycodone Hcl	Oxycodone Hcl	38	suppressed
Valsartan	Valsartan	38	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	36	11
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	35	11
Pioglitazone Hcl	Pioglitazone Hcl	35	suppressed
Valacyclovir	Valacyclovir Hcl	35	11
Carvedilol	Carvedilol	34	suppressed
Tizanidine Hcl	Tizanidine Hcl	34	16
Diclofenac Sodium	Diclofenac Sodium	33	18
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	33	suppressed
Spironolactone	Spironolactone	33	12
Ondansetron Hcl	Ondansetron Hcl	32	15
Glimepiride	Glimepiride	31	suppressed
Ventolin Hfa	Albuterol Sulfate	31	11
Isosorbide Mononitrate Er	Isosorbide Mononitrate	30	suppressed
Meclizine Hcl	Meclizine Hcl	30	14
Ibandronate Sodium	Ibandronate Sodium	29	suppressed
Naproxen	Naproxen	29	17
Farxiga	Dapagliflozin Propanediol	28	suppressed
Benazepril Hcl	Benazepril Hcl	27	suppressed
Lovastatin	Lovastatin	27	suppressed
Levofloxacin	Levofloxacin	26	20
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	26	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	25	22
Midodrine Hcl	Midodrine Hcl	25	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	24	11
Olmesartan Medoxomil	Olmesartan Medoxomil	23	suppressed
Torsemide	Torsemide	22	suppressed
Xarelto	Rivaroxaban	22	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	21	12
Lorazepam	Lorazepam	21	suppressed
Nifedipine Er	Nifedipine	21	suppressed
Paroxetine Hcl	Paroxetine Hcl	21	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	20	suppressed
Rybelsus	Semaglutide	20	suppressed
Topiramate	Topiramate	20	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	19	17
Cephalexin	Cephalexin	19	12
Clonidine Hcl	Clonidine Hcl	19	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	19	11
Tradjenta	Linagliptin	19	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	18	suppressed
Donepezil Hcl	Donepezil Hcl	18	suppressed
Glipizide	Glipizide	18	suppressed
Propranolol Hcl	Propranolol Hcl	18	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	18	suppressed
Breo Ellipta	Fluticasone/Vilanterol	17	suppressed
Cefdinir	Cefdinir	17	16
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	17	suppressed
Symbicort	Budesonide/Formoterol Fumarate	17	suppressed
Eszopiclone	Eszopiclone	16	suppressed
Finasteride	Finasteride	16	suppressed
Lamotrigine	Lamotrigine	16	suppressed
Latanoprost	Latanoprost	16	suppressed
Levemir Flexpen	Insulin Detemir	16	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	16	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	15	suppressed
Mometasone Furoate	Mometasone Furoate	15	suppressed
Promethazine Hcl	Promethazine Hcl	15	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	15	suppressed
Warfarin Sodium	Warfarin Sodium	15	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Colchicine	Colchicine	14	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	14	suppressed
Solifenacin Succinate	Solifenacin Succinate	14	suppressed
Sucralfate	Sucralfate	14	suppressed
Trulicity	Dulaglutide	14	suppressed
Bupropion Hcl Sr	Bupropion Hcl	13	suppressed
Copaxone	Glatiramer Acetate	13	suppressed
Entresto	Sacubitril/Valsartan	13	suppressed
Klor-Con M20	Potassium Chloride	13	suppressed
Lacosamide	Lacosamide	13	suppressed
Memantine Hcl	Memantine Hcl	13	suppressed
Nitroglycerin	Nitroglycerin	13	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	13	suppressed
Ondansetron Odt	Ondansetron	13	suppressed
Rabeprazole Sodium	Rabeprazole Sodium	13	suppressed
Varenicline Tartrate	Varenicline Tartrate	13	suppressed
Clobetasol Propionate	Clobetasol Propionate	12	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	12	suppressed
Enalapril Maleate	Enalapril Maleate	12	suppressed
Lidocaine	Lidocaine	12	suppressed
Myrbetriq	Mirabegron	12	suppressed
Novolog Mix 70-30	Insulin Aspart Prot/Insuln Asp	12	suppressed
Ramipril	Ramipril	12	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	12	suppressed
Lagevrio (Eua)	Molnupiravir	11	11
Otezla	Apremilast	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	suppressed
Tresiba Flextouch U-100	Insulin Degludec	11	suppressed
Wegovy	Semaglutide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error